Cardiovascular Systems Inc (CSI), a subsidiary of Abbott Laboratories, is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy systems, coronary orbital atherectomy systems, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors in the US to hospitals and clinics. CSI is headquartered in St. Paul, Minnesota, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Cardiovascular Systems Inc Company Overview
- Cardiovascular Systems Inc Company Snapshot
- Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
- Cardiovascular Systems Inc - Pipeline Analysis Overview
- Cardiovascular Systems Inc - Key Facts
- Cardiovascular Systems Inc - Major Products and Services
- Cardiovascular Systems Inc Pipeline Products by Development Stage
- Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
- Cardiovascular Systems Inc Pipeline Products Overview
- Antegrade/Retrograde Microcatheter
- Antegrade/Retrograde Microcatheter Product Overview
- Chronic Total Occlusion Catheter
- Chronic Total Occlusion Catheter Product Overview
- Complex Percutaneous Coronary Intervention Catheter
- Complex Percutaneous Coronary Intervention Catheter Product Overview
- cPCI Hemodynamic Support System
- cPCI Hemodynamic Support System Product Overview
- Fourth Generation Diamondback 360 Orbital Atherectomy System
- Fourth Generation Diamondback 360 Orbital Atherectomy System Product Overview
- Guide Extension Catheter
- Guide Extension Catheter Product Overview
- IVL System
- IVL System Product Overview
- Laser Atherectomy Device
- Laser Atherectomy Device Product Overview
- MCS System
- MCS System Product Overview
- Mixed Plaque Atherectomy System
- Mixed Plaque Atherectomy System Product Overview
- Next Gen Guide Wire
- Next Gen Guide Wire Product Overview
- Next Gen OAS System - Coronary
- Next Gen OAS System - Coronary Product Overview
- Next Generation Pump
- Next Generation Pump Product Overview
- PAD Radial Guidewire
- PAD Radial Guidewire Product Overview
- Peripheral PTA Balloon Catheter
- Peripheral PTA Balloon Catheter Product Overview
- Propel
- Propel Product Overview
- Propel Clinical Trial
- Third Generation Diamondback 360 Orbital Atherectomy System
- Third Generation Diamondback 360 Orbital Atherectomy System Product Overview
- WIRION EPD System - LE Atherectomy
- WIRION EPD System - LE Atherectomy Product Overview
- ZILIENT Guidewire - Coronary Intervention
- ZILIENT Guidewire - Coronary Intervention Product Overview
- Cardiovascular Systems Inc - Key Competitors
- Cardiovascular Systems Inc - Key Employees
- Cardiovascular Systems Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Cardiovascular Systems Inc, Recent Developments
- Oct 12, 2022: Cardiovascular Systems to Host Earnings Conference Call on November 3, 2022
- Feb 24, 2022: Cardiovascular Systems and Innova Vascular partner on thrombectomy devices
- Jan 13, 2022: Cardiovascular Systems announces development of intravascular lithotripsy technology for the treatment of coronary and peripheral artery diseases
- Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
- Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
- Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
- Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
- Oct 21, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
- Jul 14, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Fourth-Quarter Earnings Conference Call Tuesday, August 4
- Dec 16, 2019: Cardiovascular Systems, introduces peripheral orbital atherectomy system with GlideAssist in Europe
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
- Cardiovascular Systems Inc Pipeline Products by Equipment Type
- Cardiovascular Systems Inc Pipeline Products by Indication
- Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
- Cardiovascular Systems Inc, Key Facts
- Cardiovascular Systems Inc, Major Products and Services
- Cardiovascular Systems Inc Number of Pipeline Products by Development Stage
- Cardiovascular Systems Inc Pipeline Products Summary by Development Stage
- Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
- Cardiovascular Systems Inc Ongoing Clinical Trials Summary
- Antegrade/Retrograde Microcatheter - Product Status
- Antegrade/Retrograde Microcatheter - Product Description
- Chronic Total Occlusion Catheter - Product Status
- Chronic Total Occlusion Catheter - Product Description
- Complex Percutaneous Coronary Intervention Catheter - Product Status
- Complex Percutaneous Coronary Intervention Catheter - Product Description
- cPCI Hemodynamic Support System - Product Status
- cPCI Hemodynamic Support System - Product Description
- Fourth Generation Diamondback 360 Orbital Atherectomy System - Product Status
- Fourth Generation Diamondback 360 Orbital Atherectomy System - Product Description
- Guide Extension Catheter - Product Status
- Guide Extension Catheter - Product Description
- IVL System - Product Status
- IVL System - Product Description
- Laser Atherectomy Device - Product Status
- Laser Atherectomy Device - Product Description
- MCS System - Product Status
- MCS System - Product Description
- Mixed Plaque Atherectomy System - Product Status
- Mixed Plaque Atherectomy System - Product Description
- Next Gen Guide Wire - Product Status
- Next Gen Guide Wire - Product Description
- Next Gen OAS System - Coronary - Product Status
- Next Gen OAS System - Coronary - Product Description
- Next Generation Pump - Product Status
- Next Generation Pump - Product Description
- PAD Radial Guidewire - Product Status
- PAD Radial Guidewire - Product Description
- Peripheral PTA Balloon Catheter - Product Status
- Peripheral PTA Balloon Catheter - Product Description
- Propel - Product Status
- Propel - Product Description
- Propel - Cardiovascular Systems, Inc. (CSI) Percutaneous Ventricular Assist Device (pVAD) Second in Human Study
- Third Generation Diamondback 360 Orbital Atherectomy System - Product Status
- Third Generation Diamondback 360 Orbital Atherectomy System - Product Description
- WIRION EPD System - LE Atherectomy - Product Status
- WIRION EPD System - LE Atherectomy - Product Description
- ZILIENT Guidewire - Coronary Intervention - Product Status
- ZILIENT Guidewire - Coronary Intervention - Product Description
- Cardiovascular Systems Inc, Key Employees
- Glossary
- Cardiovascular Systems Inc Pipeline Products by Equipment Type
- Cardiovascular Systems Inc Pipeline Products by Development Stage
- Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardio Flow Inc
- Teleflex Inc
- Becton Dickinson and Co
- Shockwave Medical Inc
- Spectranetics Corp
- Abbott Laboratories
- Johnson & Johnson
- Avinger Inc
- Boston Scientific Corp
- Terumo Corp
- Asahi Kasei Corp
- Cook Medical Inc
- AngioDynamics Inc
- Avinger Inc
- Becton Dickinson and Co
- Boston Scientific Corp
- Shockwave Medical Inc
- Spectranetics Corp
- Ra Medical Systems Inc
- Terumo Corp
- Asahi Kasei Corp
- Cook Medical Inc
- Johnson & Johnson
- Cardio Flow Inc
- Teleflex Inc
- Medtronic Plc
- AngioDynamics Inc
- Ra Medical Systems Inc
- Medtronic Plc
